3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
23
Kidney Neoplasms
10
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma
6
Melanoma
4
Lung Neoplasms
4
Colorectal Neoplasms
4
Neoplasm Metastasis
3
Carcinoma, Hepatocellular
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Kidney Diseases
2
Clear-cell metastatic renal cell carcinoma
2
Carcinoma, Adenoid Cystic
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Skin Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Interventions
Ipilimumab
10
tremelimumab
6
durvalumab
5
Nivolumab
3
pembrolizumab
2
tilsotolimod
1
spartalizumab
1
relatlimab
1
folfirinox
1
balstilimab
1
Vemurafenib
1
Vaccines
1
Radiotherapy
1
Radiofrequency Ablation
1
Radiation
1
Paclitaxel
1
Oxaliplatin
1
Opdualag
1
Melphalan
1
Leucovorin
1
Fluorouracil
1
Docetaxel
1
Cryosurgery
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diabetes Mellitus, Insulin-Dependent, 12
×
Axitinib
×
Clear all
No trials found.